IP Library Granted Patent US 11,896,827
Granted Patent B2
US 11,896,827 · App. 15/460,702 · Granted Feb 13, 2024

Microcurrent device and method for the treatment of visual disease

Inventor: George D. O'Clock (Waconia, MN)
Assignee: MacuMira Medical Devices Inc.
A61N1/36046A61N1/36014A61N1/36034A61N1/0408
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,896,827
App. No.
15/460,702
Granted
Feb 13, 2024
Kind
B2
Abstract

An electrotherapeutic device for treating a visual disease using microcurrent stimulation is provided. The device includes a signal generator in which a waveform controller digitally controls a waveform signal source so as to generate a waveform in which one or more waveform parameters (e.g., pulse width, pulse period, pulse position, pulse coding, peak current amplitude, duty cycle, and/or pulse shape) are varied in accordance with a protocol for treating a visual disease. The device also includes an applicator connected to the signal generator and configured to apply the waveform to at least one stimulation point within an eye region.

Claims (42)

1. A method for treatment of a visual disease, comprising:

providing a signal generator comprising a waveform controller connected to a waveform signal source, wherein the waveform controller is programmed to provide an output comprising a set of waveform parameters for a visual disease treatment protocol, wherein the waveform parameters include a plurality of varying pulse frequencies, wherein the waveform signal source is operable to provide a pulsed current output, and wherein the waveform signal source is configured to receive the output from a microcontroller and generate a waveform in which a plurality of current pulses within the pulsed current output are provided at the varying pulse frequencies included in the set of waveform parameters;

providing a current control and matching circuit to maintain safe current pulse levels;

placing at least one electrode in contact with tissue of an eye region, wherein the electrode is connected to the signal generator;

activating the signal generator to apply the waveform to the tissue via the electrode;

wherein the current pulse levels do not vary by more than plus or minus 10% for load impedance variations; and

wherein the load impedance variations range from 5,000 ohms to 70,000 ohms.

2. The method of claim 1 , wherein the pulse frequencies are varied within a defined frequency range of 0.3 Hz to 300 Hz.

3. The method of claim 2 , wherein the current pulses are provided at 75% or more of the discrete frequencies within the defined frequency range.

4. The method of claim 2 , wherein the current pulses are provided at 90% or more of the discrete frequencies within the defined frequency range.

5. The method of claim 1 , wherein the pulse frequencies are varied within a defined frequency range of 0.1 Hz to 50 Hz.

6. The method of claim 5 , wherein the current pulses are provided at 75% or more of the discrete frequencies within the defined frequency range.

7. The method of claim 5 , wherein the current pulses are provided at 90% or more of the discrete frequencies within the defined frequency range.

8. The method of claim 1 , wherein the pulse frequencies are varied within a defined frequency range of 0.05 Hz to 10 Hz.

9. The method of claim 8 , wherein the current pulses are provided at 75% or more of the discrete frequencies within the defined frequency range.

10. The method of claim 8 , wherein the current pulses are provided at 90% or more of the discrete frequencies within the defined frequency range.

11. The method of claim 1 , wherein the waveform comprises a first pulse sequence and a second pulse sequence.

12. The method of claim 11 , wherein a polarity of each of the first and second pulse sequences is varied to generate a bipolar waveform.

13. The method of claim 12 , wherein the waveform parameters of the first pulse sequence are the same as the waveform parameters of the second pulse sequence.

14. The method of claim 12 , wherein the waveform parameters of the first pulse sequence are different than the waveform parameters of the second pulse sequence.

15. The method of claim 1 , wherein the visual disease comprises macular degeneration.

16. A method for treatment of a visual disease, comprising:

providing a signal generator comprising a waveform controller connected to a waveform signal source, wherein the waveform controller is programmed to provide an output with a set of waveform parameters for a visual disease treatment protocol, wherein the waveform parameters include a pulse width and a pulse frequency that is varied to provide a plurality of levels of frequency content within a sequence of current pulses, wherein the waveform signal source is operable to provide a pulsed current output, and wherein the waveform controller is operable to provide the output so as to digitally control the waveform signal source so that the waveform signal source generates a waveform comprising the sequence of current pulses having the waveform parameters for the visual disease treatment protocol;

providing a current control and matching circuit to maintain safe current pulse levels;

placing at least one electrode in contact with tissue of an eye region, wherein the electrode is connected to the signal generator;

activating the signal generator to apply the waveform to the tissue via the electrode;

wherein the current pulse levels do not vary by more than plus or minus 10% for load impedance variations; and

wherein load impedance variations range from 5,000 ohms to 70,000 ohms.

17. The method of claim 16 , wherein the set of waveform parameters is configured to vary the pulse frequency within a defined frequency range of 0.3 Hz to 300 Hz.

18. The method of claim 17 , wherein the current pulses are provided at 75% or more of the discrete frequencies within the defined frequency range.

19. The method of claim 17 , wherein the current pulses are provided at 90% or more of the discrete frequencies within the defined frequency range.

20. The method of claim 16 , wherein the set of waveform parameters is configured to vary the pulse frequency within a defined frequency range of 0.1 Hz to 50 Hz.

21. The method of claim 20 , wherein the current pulses are provided at 75% or more of the discrete frequencies within the defined frequency range.

22. The method of claim 20 , wherein the current pulses are provided at 90% or more of the discrete frequencies within the defined frequency range.

23. The method of claim 16 , wherein the set of waveform parameters is configured to vary the pulse frequency within a defined frequency range of 0.05 Hz to 10 Hz.

24. The method of claim 23 , wherein the current pulses are provided at 75% or more of the discrete frequencies within the defined frequency range.

25. The method of claim 23 , wherein the current pulses are provided at 90% or more of the discrete frequencies within the defined frequency range.

26. The method of claim 16 , wherein the waveform comprises a first pulse sequence and a second pulse sequence.

27. The method of claim 26 , wherein a polarity of each of the first and second pulse sequences is varied to generate a bipolar waveform.

28. The method of claim 27 , wherein the waveform parameters of the first pulse sequence are the same as the waveform parameters of the second pulse sequence.

29. The method of claim 27 , wherein the waveform parameters of the first pulse sequence are different than the waveform parameters of the second pulse sequence.

30. The method of claim 16 , wherein the visual disease comprises macular degeneration.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2022
From: NOVA OCULUS CANADA MANUFACTURING ULC
To: MACUMIRA MEDICAL DEVICES INC.
Reel/Frame 060854/0782 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2017
From: NOVA OCULUS PARTNERS, LLC
To: NOVA OCULUS HOLDING CO., INC.
Reel/Frame 043604/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2017
From: NOVA OCULUS HOLDING CO., INC.
To: NOVA OCULUS CANADA MANUFACTURING ULC
Reel/Frame 043604/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2017
From: O'CLOCK, GEORGE D.
To: THE EYE MACHINE, LLC
Reel/Frame 041597/0383 →
CHANGE OF NAME Recorded Mar 16, 2017
From: THE EYE MACHINE, LLC
To: NOVA OCULUS PARTNERS, LLC
Reel/Frame 042027/0654 →
Continuity (2)
Continuation 15071912 · Mar 16, 2016
Related Publication 20170266446A1 · Sep 21, 2017